Evidence map›Paper›PMID 33119549›Full record

ArticleJCI insight2020

Smooth muscle-derived progenitor cell myofibroblast differentiation through KLF4 downregulation promotes arterial remodeling and fibrosis.

Sizhao Lu, Austin J Jolly, Keith A Strand, Allison M Dubner, Marie F Mutryn, Karen S Moulton, Raphael A Nemenoff, Mark W Majesky, Mary Cm Weiser-Evans

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 52 citations in OpenAlex.

  1. Novel netrin-1-Unc5b-Klf4 axis balances AT2 survival in experimental bronchopulmonary dysplasia.American journal of respiratory cell and molecular biology · 2026
    Article
  2. Article
  3. Contribution of Gli1Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. bioRxiv : the preprint server for biology · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. The TNFThe American journal of pathology · 2023
    Article
  19. Article
  20. Mammalian organ regeneration in spiny mice.Journal of muscle research and cell motility · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Sizhao LuDivision of Renal Diseases and Hypertension, Department of Medicine, and.
Austin J JollyDivision of Renal Diseases and Hypertension, Department of Medicine, and.
Keith A StrandDivision of Renal Diseases and Hypertension, Department of Medicine, and.
Allison M DubnerDivision of Renal Diseases and Hypertension, Department of Medicine, and.
Marie F MutrynDivision of Renal Diseases and Hypertension, Department of Medicine, and.
Karen S MoultonDivision of Cardiology, Department of Medicine, and.
Raphael A NemenoffDivision of Renal Diseases and Hypertension, Department of Medicine, and.
Mark W MajeskyCenter for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, Washington, USA.
Mary Cm Weiser-EvansDivision of Renal Diseases and Hypertension, Department of Medicine, and.
University of Colorado Anschutz Medical Campus · USEmory University Hospital · USSeattle Children's Hospital · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Medical Scientist Training ProgramT32GM008497 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI WILSON, CARA C. · 1993 to 2022
$15.2M
Reprogramming of mature smooth muscle cells to vascular progenitor cellsR01HL121877 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MARK W. MAJESKY, Mary CM Weiser-Evans · 2015 to 2026
$7.8M
PREDOCTORAL TRAINING PROGRAM IN PHARMACOLOGYT32GM007635 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI DELL'ACQUA, MARK L · 1985 to 2023
$6.1M
PTEN promoter hypermethylation underlies vascular disease progressionR01HL151331 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI WEISER-EVANS, MARY CM · 2021 to 2024
$2.3M
PTEN-dependent regulation of SRF transcriptional activity and SMC phenotype controlR01HL123616 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI WEISER-EVANS, MARY CM. · 2015 to 2018
$2.0M
Pharmacologic PTEN upregulation: A novel therapeutic approach to prevent pathological vascular remodeling and fibrosisF31HL147393 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI STRAND, KEITH · 2019 to 2020
$53k
American Heart Association-American Stroke Association 18POST34030397NCATS NIH HHS UL1 TR001082NCI NIH HHS P30 CA046934NHLBI NIH HHS F31 HL147393NHLBI NIH HHS R01 HL121877NHLBI NIH HHS R01 HL123616NHLBI NIH HHS R01 HL151331NIGMS NIH HHS T32 GM007635NIGMS NIH HHS T32 GM008497
6 · The paper itself

Abstract

Resident vascular adventitial SCA1+ progenitor (AdvSca1) cells are essential in vascular development and injury. However, the heterogeneity of AdvSca1 cells presents a unique challenge in understanding signaling pathways orchestrating their behavior in homeostasis and injury responses. Using smooth muscle cell (SMC) lineage-tracing models, we identified a subpopulation of AdvSca1 cells (AdvSca1-SM) originating from mature SMCs that undergo reprogramming in situ and exhibit a multipotent phenotype. Here we employed lineage tracing and RNA-sequencing to define the signaling pathways regulating SMC-to-AdvSca1-SM cell reprogramming and AdvSca1-SM progenitor cell phenotype. Unbiased hierarchical clustering revealed that genes related to hedgehog/WNT/beta-catenin signaling were significantly enriched in AdvSca1-SM cells, emphasizing the importance of this signaling axis in the reprogramming event. Leveraging AdvSca1-SM-specific expression of GLI-Kruppel family member GLI1 (Gli1), we generated Gli1-CreERT2-ROSA26-YFP reporter mice to selectively track AdvSca1-SM cells. We demonstrated that physiologically relevant vascular injury or AdvSca1-SM cell-specific Kruppel-like factor 4 (Klf4) depletion facilitated the proliferation and differentiation of AdvSca1-SM cells to a profibrotic myofibroblast phenotype rather than macrophages. Surprisingly, AdvSca1-SM cells selectively contributed to adventitial remodeling and fibrosis but little to neointima formation. Together, these findings strongly support therapeutics aimed at preserving the AdvSca1-SM cell phenotype as a viable antifibrotic approach.

Indexed as

AnimalsArteriesCell DifferentiationFemaleFibrosisHumansKruppel-Like Factor 4Kruppel-Like Transcription FactorsMaleMiceMice, Inbred C57BLMice, TransgenicMuscle, Smooth, VascularMyocytes, Smooth MuscleMyofibroblastsStem CellsKLF4 protein, humanKlf4 protein, mouseKruppel-Like Factor 4Kruppel-Like Transcription FactorsAdult stem cellsFibrosisStem cellsVascular Biology

Identifiers

PMID33119549
PMCPMC7714399
OpenAlexW3096282850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.